big data scientists
BigData
cardiovascular big-data science
data sets
big data science expertise
analysis of distributed data
management of cardiovascular disease
heart failure
disease registries
CVD drug candidate
current treatment
disease definitions
relevant disease phenotypes
CVD field
unparalleled array of big
disease category
clinical markers
well-phenotyped clinical trials
major challenges
management of HF
clinical researchers
relevant stakeholders
new framework
relevant large-scale European CVD databases
drug development pipelines
global CVD burden
large trials of unselected patients
large e
patient organisations
patient death
undetectable treatment effects
quality of life
AF
scientific evidence
better definition
QoL
Today’s treatment guidelines
ACS
agile research framework
heterogeneous prognoses
Optimal management
novel frameworks
better segmentation of current heterogeneous patient groups
major unmet needs
unique database access
scalable insights
therapy unpredictable
real-world evidence
leading epidemiologists
large inter-individual variation
scientific constraints
key players
wide dissemination
project results
Poor definition
wide variations
translational research platform of unparalleled scale
powerful group of players
early target validation
electronic health records
order
multi-morbidities
number of pilot studies
remarkable progress
molecular level
mortality
phenotypic resolution
regard
underlying mechanisms
personalised medicine
atrial fibrillation
growing components
late post-marketing work
main endpoint
end-organ damage
conventional risk factors
chance of eventual approval
functional capacity
earlier era
durable standards
solutions
combination
comorbidities
identification
adherence
diseases
hospitalisations
endpoints
harmonisation
immediate social relevance
different sources
advanced analytics
insurers
Acute coronary syndrome
outcomes
conditions
impact
complex aetiology
healthcare expenditures
policy makers
tweak
Heart’s ultimate goal
Phase
forces
delivery of targeted treatments
pharmaceutical industry
renders response
tolerability of medication
inspiration
rest
productivity
speed
support
objectives
partners
template
systems
team
oncology
decades